Newbury Pharma is a rapidly growing hybrid pharmaceutical company focused on specialty prescription drugs, innovation, and branded products. The company aims to impact society positively by bringing products and technology that contribute to healthcare systems and patient wellbeing. Newbury Pharmaceuticals is developing a pipeline of proprietary and licensed products with a focus on oncology, rare diseases, and neurology.

Newbury Pharma

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.

Newbury Pharmaceuticals AB (publ)

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 7:06 PM	69cb325b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 7:06 PM	1d272645
crunchbase trigger	general	Nov 27, 2024 12:50 PM	fd3d67ea
crunchbase profile	general
li profile	general
translate crunchbase fundingrounds	general
peers	general	Sep 27, 2024 7:06 PM	24f49505
news basic	general	Sep 27, 2024 7:06 PM	2526f4be
bundesanzeiger	filings
financials download nd	financials
private financials	financials

NEWB

COM:NEWBURYPHARMA

Newbury Pharma

Last Close

3.32

25/11 08:40

Market Cap

91.21M

Beta: -

Volume Today

4.70K

Avg: -